Ligand to Report Fourth Quarter Financial Results on February 22

Go back to Ligand to Report Fourth Quarter Financial Results on February 22
LIGAND PHARMA (NASDAQ: LGND) Delayed: 280.18 -6.11 (2.13%)
Previous Close $286.29    52 Week High $139.79 
Open $286.27    52 Week Low $82.07 
Day High $286.27    P/E 651.58 
Day Low $279.87    EPS $0.43 
Volume 158,236